Patents by Inventor Robert Evans

Robert Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260103534
    Abstract: Methods of administering isolated anti-CD38 antibodies at low dosages subcutaneously are disclosed. The methods provide an effective treatment for autoimmune diseases and cancers, including hematologic diseases. Also disclosed are unit dosage forms for the anti-CD38 antibodies.
    Type: Application
    Filed: June 23, 2025
    Publication date: April 16, 2026
    Inventors: Martin Dahl, Eric Fedyk, Robert Evans, Lin Zhao
  • Patent number: 12371506
    Abstract: Methods of administering isolated anti-CD38 antibodies at low dosages subcutaneously are disclosed. The methods provide an effective treatment for autoimmune diseases and cancers, including hematologic diseases. Also disclosed are unit dosage forms for the anti-CD38 antibodies.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: July 29, 2025
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Martin Dahl, Eric Fedyk, Robert Evans, Lin Zhao
  • Publication number: 20250059596
    Abstract: The present invention provides for methods and compositions for one-pot Golden Gate cloning, or conventional two-pot restriction enzyme cloning, regardless of internal restriction sites. It uses modified nucleotides during PCR of DNA, or through post-hoc enzymatic modification of already existing DNA, wherein the modification blocks the internal restriction sites while leaving the flanking restriction sites unblocked.
    Type: Application
    Filed: July 29, 2024
    Publication date: February 20, 2025
    Inventor: Robert EVANS
  • Publication number: 20240343272
    Abstract: A magnetic traction assembly is disclosed for a railcar mover that provides additional downforce to improve traction for a railcar mover when required. The magnetic traction assembly may comprise a frame, an actuator, and a magnetic element positioned underneath a railcar mover. The magnetic element may be lowered to a deployed position, where the magnetic element is positioned near the railroad rails such that the magnetic field from the magnetic element interacts with the railroad rail creating an attraction force that provides additional downforce to the railcar mover.
    Type: Application
    Filed: November 20, 2023
    Publication date: October 17, 2024
    Applicant: Trackmobile LLC
    Inventors: Robert EVANS, Jeffrey LOONEY, Kevin GROVER, Calvin WAGNER, Marco MATTIOLI
  • Publication number: 20240082380
    Abstract: The present invention provides methods for enhancing the efficacy and/or safety of a vaccine. In certain embodiments, the invention provides methods to increase or potentiate the immune response to a vaccine in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody in combination with said vaccine. In certain embodiments, the methods of the present invention are used to afford enhanced protection to an infectious disease such as whooping cough.
    Type: Application
    Filed: July 5, 2023
    Publication date: March 14, 2024
    Inventors: Lisa Purcell, Neil Graham, Andrew J. Murphy, Robert Evans
  • Patent number: 11820406
    Abstract: A magnetic traction assembly is disclosed for a railcar mover that provides additional downforce to improve traction for a railcar mover when required. The magnetic traction assembly may comprise a frame, an actuator, and a magnetic element positioned underneath a railcar mover. The magnetic element may be lowered to a deployed position, where the magnetic element is positioned near the railroad rails such that the magnetic field from the magnetic element interacts with the railroad rail creating an attraction force that provides additional downforce to the railcar mover.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: November 21, 2023
    Assignee: Trackmobile LLC
    Inventors: Robert Evans, Jeffrey Looney, Kevin Grover, Calvin Wagner, Marco Mattioli
  • Publication number: 20220213519
    Abstract: In an aspect, the disclosure provides methods for making neurotransmitters in a host organism. The neurotransmitters can be cannabinoids and derivatives of cannabinoids. The host cells can be microalgae, fungi or other host cells. In a related aspect, the disclosure provides host cells engineered to have biochemical pathways for making neurotransmitters such as cannabinoids.
    Type: Application
    Filed: March 25, 2022
    Publication date: July 7, 2022
    Applicant: Purissima, Inc.
    Inventors: George Rudenko, Robert Evans
  • Publication number: 20220204631
    Abstract: The present invention provides methods for decreasing a nasal polyp score in a subject. The methods include administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody or antigen binding fragment thereof.
    Type: Application
    Filed: November 23, 2021
    Publication date: June 30, 2022
    Inventors: Leda Mannent, Gianluca Pirozzi, Brian Swanson, Allen Radin, Namita A. Gandhi, Robert Evans, Jennifer Hamilton
  • Publication number: 20220188890
    Abstract: A system and a method of facilitating purchase and/or lease of an automobile are disclosed. The system Automotive Sales Representative receives information from a customer or buyer for purchasing and/or leasing an automobile. The system allows an automotive retail sales or leasing representative to select one or more automobiles based on the information provided by the customer. The system selects purchase options for the customer. Further, the system selects a dealership which offers best pricing for the automobile suitable for the customer. The system checks inventory at the dealership and obtains an invoice from the dealership. Subsequently, the system checks rebates, insurance and other finance and insurance data applicable for the customer. Further, the system generates a deal structure or buyer order and transmits to the customer. The system allows automotive retail sales representatives to provide a buyer order or sales quote instantly to the customer.
    Type: Application
    Filed: December 14, 2021
    Publication date: June 16, 2022
    Inventors: Robert Evans, James Evans
  • Publication number: 20220186270
    Abstract: In an aspect, the disclosure provides methods for making neurotransmitters in a host organism. The neurotransmitters can be cannabinoids and derivatives of cannabinoids. The host cells can be microalgae, fungi or other host cells. In a related aspect, the disclosure provides host cells engineered to have biochemical pathways for making neurotransmitters such as cannabinoids.
    Type: Application
    Filed: February 25, 2022
    Publication date: June 16, 2022
    Applicant: Purissima, Inc.
    Inventors: George Rudenko, Robert Evans
  • Patent number: 11293041
    Abstract: In an aspect, the disclosure provides methods for making neurotransmitters in a host organism. The neurotransmitters can be cannabinoids and derivatives of cannabinoids. The host cells can be microalgae, fungi or other host cells. In a related aspect, the disclosure provides host cells engineered to have biochemical pathways for making neurotransmitters such as cannabinoids.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: April 5, 2022
    Assignee: Purissima, Inc.
    Inventors: George Rudenko, Robert Evans
  • Patent number: 11261469
    Abstract: In an aspect, the disclosure provides methods for making neurotransmitters in a host organism. The neurotransmitters can be cannabinoids and derivatives of cannabinoids. The host cells can be microalgae, fungi or other host cells. In a related aspect, the disclosure provides host cells engineered to have biochemical pathways for making neurotransmitters such as cannabinoids.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: March 1, 2022
    Assignee: Purissima, Inc.
    Inventors: George Rudenko, Robert Evans
  • Publication number: 20220054060
    Abstract: This disclosure relates to a system and method for drawing blood from a user by skin puncture instead of venous puncture and storing it for analysis. The system includes a receptacle configured to engage an area of skin of the user at a blood draw location and store blood drawn from the user; a lancet device disposed within the receptacle configured to puncture the skin of the user at the blood draw location; a vacuum device configured to reduce a pressure within the receptacle such that the skin at the blood draw location is drawn into the receptacle before the lancet device punctures the skin, and to enhance blood flow while blood is drawn from the user; and a housing configured to house the receptacle, the lancet device, and the vacuum device. The receptacle, the lancet device, and the vacuum device may be modular and removably coupled with the housing.
    Type: Application
    Filed: October 22, 2021
    Publication date: February 24, 2022
    Applicant: INVITAE CORPORATION
    Inventors: Sean Emerson GEORGE, Nathan MCDONALD, Eric OLIVARES, Robert EVANS
  • Patent number: 11242546
    Abstract: In an aspect, the disclosure provides methods for making neurotransmitters in a host organism. The neurotransmitters can be cannabinoids and derivatives of cannabinoids. The host cells can be microalgae, fungi or other host cells. In a related aspect, the disclosure provides host cells engineered to have biochemical pathways for making neurotransmitters such as cannabinoids.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: February 8, 2022
    Assignee: Purissima, Inc.
    Inventors: George Rudenko, Robert Evans
  • Patent number: 11242547
    Abstract: In an aspect, the disclosure provides methods for making neurotransmitters in a host organism. The neurotransmitters can be cannabinoids and derivatives of cannabinoids. The host cells can be microalgae, fungi or other host cells. In a related aspect, the disclosure provides host cells engineered to have biochemical pathways for making neurotransmitters such as cannabinoids.
    Type: Grant
    Filed: June 8, 2021
    Date of Patent: February 8, 2022
    Assignee: Purissima, Inc.
    Inventors: George Rudenko, Robert Evans
  • Patent number: 11214621
    Abstract: The present invention provides methods for decreasing a nasal polyp score in a subject. The methods include administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: January 4, 2022
    Assignees: SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS, INC.
    Inventors: Leda Mannent, Gianluca Pirozzi, Brian Swanson, Allen Radin, Namita A. Gandhi, Robert Evans, Jennifer Hamilton
  • Publication number: 20210388103
    Abstract: Methods of administering isolated anti-CD38 antibodies at low dosages subcutaneously are disclosed. The methods provide an effective treatment for autoimmune diseases and cancers, including hematologic diseases. Also disclosed are unit dosage forms for the anti-CD38 antibodies.
    Type: Application
    Filed: January 14, 2019
    Publication date: December 16, 2021
    Inventors: Martin Dahl, Eric Fedyk, Robert Evans, Lin Zhao
  • Patent number: 11193151
    Abstract: In an aspect, the disclosure provides methods for making neurotransmitters in a host organism. The neurotransmitters can be cannabinoids and derivatives of cannabinoids. The host cells can be microalgae, fungi or other host cells. In a related aspect, the disclosure provides host cells engineered to have biochemical pathways for making neurotransmitters such as cannabinoids.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: December 7, 2021
    Assignee: Purissima, Inc.
    Inventors: George Rudenko, Robert Evans
  • Patent number: 11166658
    Abstract: This disclosure relates to a system and method for drawing blood from a user by skin puncture instead of venous puncture and storing it for analysis. The system includes a receptacle configured to engage an area of skin of the user at a blood draw location and store blood drawn from the user; a lancet device disposed within the receptacle configured to puncture the skin of the user at the blood draw location; a vacuum device configured to reduce a pressure within the receptacle such that the skin at the blood draw location is drawn into the receptacle before the lancet device punctures the skin, and to enhance blood flow while blood is drawn from the user; and a housing configured to house the receptacle, the lancet device, and the vacuum device. The receptacle, the lancet device, and the vacuum device may be modular and removably coupled with the housing.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: November 9, 2021
    Assignee: INVITAE CORPORATION
    Inventors: Sean Emerson George, Nathan McDonald, Eric Olivares, Robert Evans
  • Publication number: 20210317491
    Abstract: In an aspect, the disclosure provides methods for making neurotransmitters in a host organism. The neurotransmitters can be cannabinoids and derivatives of cannabinoids. The host cells can be microalgae, fungi or other host cells. In a related aspect, the disclosure provides host cells engineered to have biochemical pathways for making neurotransmitters such as cannabinoids.
    Type: Application
    Filed: June 22, 2021
    Publication date: October 14, 2021
    Applicant: Purissima, Inc.
    Inventors: George Rudenko, Robert Evans